J B Chem sells Russia-CIS prescription drugs business to Dr Reddy'sIllustrative image – not actual.
J B Chemicals & Pharmaceuticals (JBCPL) has signed an agreement to sell its prescription medicine portfolio to Dr Reddy's Laboratories.
 
The agreement involves acquisition of 20 brands, key ones being Metrogyl and Jocet, for a consideration of Rs 137.5 crore. DRL has also entered into a supply agreement with J B Chemicals for the continued manufacturing and supply of these products associated with the acquired brands. Bank of America Merrill Lynch is acting as exclusive financial advisor to JBCPL.

← All latest storiesBack to top →